Screening for cervical cancer: Will women accept less?

被引:56
作者
Sirovich, BE
Woloshin, S
Schwartz, LM
机构
[1] Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA
[2] Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Hanover, NH USA
[3] Ctr Evaluat Clin Sci Dartmouth, Hanover, NH USA
关键词
Pap smear screening; test frequency; knowledge and attitudes;
D O I
10.1016/j.amjmed.2004.08.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: U.S. professional organizations increasingly agree that most women require Papanicolaou smear screening every 2 to 3 years rather than annually and that most elderly women may stop screening. We sought to describe the attitudes of women in the United States toward less intense screening, specifically, less frequent screening and eventual cessation of screening. METHODS: We conducted a random-digit-dialing telephone survey of women in 2002 (response rate of 75% among eligible women reached by telephone). A nationally representative sample of 360 women aged 40 years or older with no history of cancer was surveyed about their acceptance of less intense screening. RESULTS: Almost all women aged 40 years or older (99%) had had at least one Pap smear; most (59%) were screened annually. When women were asked to choose their preferred frequency for screening, 75% preferred screening at least annually (12% chose screening every 6 months). Less than half (43%) had heard of recommendations advocating less frequent screening. When advised of such recommendations, half of all women believed that they were based on cost. Sixty-nine percent said that they would try to continue being screened annually even if their doctors recommended less frequent screening and advised them of comparable benefits. Only 35% of women thought that there might come a time when they would stop getting Pap smears; of these, almost half would not stop until after age 80 years. The strongest predictor of reluctance to reduce the frequency of screening was a belief that cost was the basis of current screening frequency recommendations. CONCLUSION: Most women in the United States prefer annual Pap smears and are resistant to the idea of less intense screening. Concern that cost considerations rather than evidence form the basis of screening recommendations may partly explain women's reluctance to accept less intense screening. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 18 条
[11]   Impact of a new cervical Pap smear screening guideline on member perceptions and comfort levels [J].
Rolnick, SJ ;
LaFerla, JJ ;
Jackson, J ;
Akkerman, D ;
Compo, R .
PREVENTIVE MEDICINE, 1999, 28 (05) :530-534
[12]   American Cancer Society guideline for the early detection of cervical neoplasia and cancer [J].
Saslow, D ;
Runowicz, CD ;
Solomon, D ;
Moscicki, AB ;
Smith, RA ;
Eyre, HJ ;
Cohen, C .
CA-A CANCER JOURNAL FOR CLINICIANS, 2002, 52 (06) :342-362
[13]   Risk of cervical cancer associated with extending the interval between cervical-cancer screenings [J].
Sawaya, GF ;
McConnell, KJ ;
Kulasingam, SL ;
Lawson, HW ;
Kerlikowske, K ;
Melnikow, J ;
Lee, NC ;
Gildengorin, G ;
Myers, ER ;
Washington, AE .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1501-1509
[14]   The positive predictive value of cervical smears in previously screened postmenopausal women: The Heart and Estrogen/progestin Replacement Study (HERS) [J].
Sawaya, GF ;
Grady, D ;
Kerlikowske, K ;
La Valleur, J ;
Barnabei, VM ;
Bass, K ;
Snyder, TE ;
Pickar, JH ;
Agarwal, SK ;
Mandelblatt, J .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (12) :942-950
[15]   Enthusiasm for cancer screening in the United States [J].
Schwartz, LM ;
Woloshin, S ;
Fowler, FJ ;
Welch, HG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (01) :71-78
[16]   Withdrawing low risk women from cervical screening programmes: mathematical modelling study [J].
Sherlaw-Johnson, C ;
Gallivan, S ;
Jenkins, D .
BRITISH MEDICAL JOURNAL, 1999, 318 (7180) :356-360
[17]   The frequency of Pap smear screening in the United States [J].
Sirovich, BE ;
Welch, HG .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (03) :243-250
[18]  
2000, MMWR MORB MORTAL WKL, V49, P1001